mavorixafor

1,4-Butanediamine, N~1~-(1H-benzimidazol-2-ylmethyl)-N~1~-(5,6,7,8-tetrahydro-8-quinolinyl)-

558447-26-0

mavorixafor

N-(1H-Benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydro-8-chinolinyl)-1,4-butandiamin

N-(1H-Benzimidazol-2-ylméthyl)-N-(5,6,7,8-tétrahydro-8-quinoléinyl)-1,4-butanediamine

N-(1H-Benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine

N-(4-AMINOBUTYL)-N-(1H-1,3-BENZODIAZOL-2-YLMETHYL)-5,6,7,8-TETRAHYDROQUINOLIN-8-AMINE

N-(4-aminobutyl)-N-[(1H-1,3-benzodiazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine

(4-aminobutyl)(benzimidazol-2-ylmethyl)-8-5,6,7,8-tetrahydroquinolylamine

(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

558441-90-0

AMD 070; AMD070

MFCD11977316

N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine

N′-(1H-Benzimidazol-2-ylmethyl)-N′-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine